Susanne Muehlich
Erlangen, BY 91058, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Filamin a binds deleted in liver cancer 1 (DLC1) to promote its tumor suppressor activity and inhibit the SRF coactivator MRTF-A.
Journal: Neoplasia (New York, N.Y.)
Published: September 19, 2025
Identification of novel inhibitors of the transcriptional coactivator MRTF-A for HCC therapy.
Journal: Molecular therapy. Oncology
Published: May 01, 2024
Synthesis, Characterization, and Application of Muscarinergic M3 Receptor Ligands Linked to Fluorescent Dyes.
Journal: Journal of medicinal chemistry
Published: December 09, 2022
LPA receptor 1 (LPAR1) is a novel interaction partner of Filamin A that promotes Filamin A phosphorylation, MRTF-A transcriptional activity and oncogene-induced senescence.
Journal: Oncogenesis
Published: July 07, 2022
ATF2 loss promotes tumor invasion in colorectal cancer cells via upregulation of cancer driver TROP2.
Journal: Cellular and molecular life sciences : CMLS
Published: April 12, 2022
Tetraspanin 5 (TSPAN5), a Novel Gatekeeper of the Tumor Suppressor DLC1 and Myocardin-Related Transcription Factors (MRTFs), Controls HCC Growth and Senescence.
Journal: Cancers
Published: August 04, 2021
Molecular Mechanisms to Target Cellular Senescence in Hepatocellular Carcinoma.
Journal: Cells
Published: October 03, 2020
Inhibition of TRPM7 blocks MRTF/SRF-dependent transcriptional and tumorigenic activity.
Journal: Oncogene
Published: June 10, 2019
TRPM7 kinase activity is essential for T cell colonization and alloreactivity in the gut.
Journal: Nature communications
Published: November 25, 2016
Last Updated: 09/26/2026